ECOLAB INC. Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Two
ECOLAB INC. (ECL) had Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Two of $1.00 million as of 2015-12-31, per its 10-K filed 2016-02-26.
Discontinued › Notes › Compensation Related Costs › Retirement Benefits › Defined Benefit Plan › Defined Benefit Plan, Expected Amounts › Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt
us-gaap:PrescriptionDrugSubsidyReceiptsYearTwo1 · last filed 2016-02-26
- 2015-12-31: Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Two $1.00M.
- 2013-12-31: Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Two $2.00M.
- 2012-12-31: Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Two $2.00M.
| Period end | Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Two |
|---|---|
| 2015-12-31 | $1.00M 10-K · filed 2016-02-26 |
| 2013-12-31 | $2.00M 10-K · filed 2014-02-28 |
| 2012-12-31 | $2.00M 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHURCH & DWIGHT CO INC /DE/ (CHD) | United States | $22.622B | 30.81 |
| STEPAN CO (SCL) | United States | $1.451B | -477.05 |
| Longevity Health Holdings, Inc. (XAGE) | United States | $0.006B | -0.09 |
| PROCTER & GAMBLE Co (PG) | United States | $338.763B | 21.26 |